PAADX
Price
$16.96
Change
+$0.08 (+0.47%)
Updated
Aug 6 closing price
Net Assets
2.25B
RLBCX
Price
$36.81
Change
+$0.10 (+0.27%)
Updated
Aug 6 closing price
Net Assets
253.12B
Interact to see
Advertisement

PAADX vs RLBCX

Header iconPAADX vs RLBCX Comparison
Open Charts PAADX vs RLBCXBanner chart's image
Putnam Dynamic Asset Allocation Bal R5
Price$16.96
Change+$0.08 (+0.47%)
VolumeN/A
Net Assets2.25B
American Funds American Balanced R3
Price$36.81
Change+$0.10 (+0.27%)
VolumeN/A
Net Assets253.12B
PAADX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PAADX vs. RLBCX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAADX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 253B vs. PAADX (2.25B). PAADX pays higher dividends than RLBCX: PAADX (3.14) vs RLBCX (1.56). PAADX was incepted earlier than RLBCX: PAADX (13 years) vs RLBCX (23 years). RLBCX (0.89) is less costly to investors than PAADX (0.71). PAADX is a more actively managed with annual turnover of: 222.00 vs. RLBCX (44.00). PAADX has a lower initial minimum investment than RLBCX: PAADX (0) vs RLBCX (250). RLBCX annual gain was more profitable for investors over the last year : 10.44 vs. PAADX (5.93). RLBCX return over 5 years is better than : 34.86 vs. PAADX (20.15).
PAADXRLBCXPAADX / RLBCX
Total Expense Ratio0.710.8980%
Annual Report Gross Expense Ratio0.710.8980%
Fund Existence13 years23 years-
Gain YTD8.0578.41896%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.25B253B1%
Annual Yield % from dividends3.141.56202%
Returns for 1 year5.9310.4457%
Returns for 3 years23.1530.1777%
Returns for 5 years20.1534.8658%
Returns for 10 years36.2261.8459%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRN148.3220.09
+15.67%
Stride
CFG46.93-0.37
-0.78%
Citizens Financial Group
CMPS4.36-0.12
-2.68%
COMPASS Pathways Plc
CNTB2.13-0.07
-3.18%
Connect Biopharma Holdings Limited
APRE1.64-0.15
-8.38%
Aprea Therapeutics